Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. How to Use the Data.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

AUGUST 17, 2021

Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. Key Topics Covered: 1.0 Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

OCTOBER 10, 2021

As a think tank we develop new ideas and concepts for providing medical cannabis to patients both in Germany and Europe. Cantourage is an innovative company ensuring that patients are able to access the newest medicinal products based on cannabis. “Development by innovation” is not an empty promise but our daily work motivator.

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

Cannabis Law Report

MARCH 1, 2022

A fast-paced environment where you’ll work on a wide range of topics. Become part of creating a radically new and impactful paradigm shift in drug development and patient care. 10 years of experience in the pharmaceutical industry. +5 Opportunity. An open, results-driven, and meritocratic start-up culture.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

The Cannigma

MARCH 7, 2022

What can the current clinical trials tell us? A common theme with cannabis is that more research is needed, so thankfully there are clinical trials in the works looking at the therapeutic utility of CBN. Those recruited will apply either CBN cream or placebo to non-wounded areas over a course of 28 days.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

OCTOBER 2, 2021

A fast-paced environment where you’ll work on a wide range of topics. Become part of creating a radically new and impactful paradigm shift in drug development and patient care. 10 years of experience in the pharmaceutical industry. +5 Opportunity. An open, results-driven, and meritocratic start-up culture.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

JULY 29, 2021

The Medical Division is launching its first six Opitcann medical “CB4” line of branded products to be sold through medical channel partners and through Heritage Patient Care starting in August 2021. About Heritage Cannabis Holdings Corp. operating under two licensed manufacturing facilities in Canada.

Recreational 98

Recreational Vaping Concentrates Clinical Trials 98

Cannabis Law Report

SEPTEMBER 6, 2021

GW Pharmaceuticals. For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to reduce the dosage and frequency of opioids significantly and imparts greater pain relief.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. The only side effects reported from Epidiolex clinical trials were sleepiness, sedation, insomnia, fatigue, diarrhea, rash, and some infections.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

JUNE 25, 2021

Major players in the global skin cancer drugs market are Novartis AG, Bristol Myers Squibb, Eli Lilly, Meda, and Sun Pharmaceutical Industries Ltd. EMA also regulates and supervises the drug quality, check for the intended use of the drug and whether the drug is meeting the requirement of clinical trial. Key Topics Covered: 1.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. How classical pharmaceuticals fight HIV. Cannabis as a palliative aid for HIV patients. What is HIV and how is it manifested?

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

For example, many anti-anxiety pharmaceuticals are habit-forming, entail significant negative side effects, and can also cause physical problems such as diminished mobility or coordination. Ultimately, cannabis for mental health seems to boil down to questions of individual patient suitability. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Canna Care Docs

DECEMBER 11, 2018

A study published in the journal, Chemistry & Biodiversity , noted “marked improvement” in the quality of sleep in patients with chronic pain problems. [5] Another important aspect for seniors is that medicinal cannabis users tend to take less pharmaceutical drugs. Here, too, cannabis has been shown to have a distinct effect.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. for the production of cannabis used in federally-regulated clinical trials.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Miss Marijuana

MAY 13, 2020

Topicals – These are a common way to use CBD for skin conditions or joint/pain issues. If you’re worried about taking too much, just know that clinical trials have prescribed CBD doses up to 1,200 mg daily for months without observing any serious side effects. Topical or inhaled products help minimize this interaction.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

Cannabis Law Report

FEBRUARY 3, 2022

Patients suffering from chronic diseases, like Parkinson’s, Alzheimer’s, cancer, and many neurological disorders, are administered cannabis. The presence of major key players, pharmaceutical and biotechnology industries worldwide, and their experimental approach drives the cannabis market growth. Gw Pharmaceuticals plc.

Indica 52

Indica Oil Legalization Research and Development 52

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. Mitchell et al., Divito & Robert F. 15 × 15. 16 × 16.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Medical Cannabis Seedbank

FEBRUARY 26, 2018

Cannabis and cancer, quite a popular topic, however, many people have to face the reality of either; dealing with cancer themselves or having an immediate family member or friend having to fight the deadly disease. A regular occurrence amongst cancer patients being treated with chemotherapy is intense bouts of nausea, vomiting, and retching.

Treatment 63

Treatment Patients Clinical Trials THC 63

The Cannigma

JUNE 24, 2021

While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. Nausea and vomiting — cannabis has long been seen as a potential supportive treatment option for cancer patients undergoing chemotherapy.

CBD 75

CBD Microdosing Edibles Sleep 75

Miss Marijuana

MAY 13, 2020

Topicals – These are a common way to use CBD for skin conditions or joint/pain issues. If you’re worried about taking too much, just know that clinical trials have prescribed CBD doses up to 1,200 mg daily for months without observing any serious side effects. Topical or inhaled products help minimize this interaction.

CBD 52

CBD Blood Pressure Clinical Trials Tincture 52

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. a leading clinical trial services company, for a First in Human study investigating Epoladerm™ for pain associated with osteoarthritis of the knee. About Virpax Pharmaceuticals.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

JANUARY 24, 2022

where marijuana for recreational use has been legalized, the market has witnessed a dynamic shift of patients from traditional methods or medicine to opting to use marijuana for medical and other purposes. Key Topics Covered: Chapter 1 Methodology and Scope. North America Legal Cannabis Number of clinical trials.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. About Virpax Pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. It covers the pipeline drug profiles, including clinical and nonclinical stage products. Ganaxolone: Marinus Pharmaceuticals. Epilepsy Emerging Drugs.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. I’ve seen it as flower, I’ve seen it as topical, which has anti-bacterial and anti-psoriatic effects. CannMed: I’m glad you brought up ADHD.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. How to dose CBD.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

DECEMBER 28, 2021

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

FloridaMarijuana.net

AUGUST 13, 2018

There are a variety of treatment options to help patients cope with and heal from anxiety disorders. Pharmaceuticals come with side effects, though, and may vary from person-to-person. Medical marijuana is another option for patients suffering from anxiety. Medications can be used along with therapy.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed October 17, 2022. Miller OS, Elder EJ, Jones KJ, Gidal BE.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 22, 2021

The drug is currently in phase III stage of development for the treatment of spasticity in patients with multiple sclerosis not showing sufficient response to their current anti-spasticity treatment. Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. Key Players.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

FloridaMarijuana.net

OCTOBER 19, 2018

Some patients find success with pharmaceuticals and talk-therapy. In addition to these medical interventions, Medical marijuana may also be beneficial to clinically depressed patients. Medical marijuana is another option for patients suffering from anxiety. Depression can be treated several ways.

Marijuana 189

Marijuana Research and Development Patients Clinical Trials 189

Cannabis Law Report

OCTOBER 18, 2021

The drug is currently in phase III stage of development for the treatment of spasticity in patients with multiple sclerosis not showing sufficient response to their current anti-spasticity treatment. Lenabasum: Corbus Pharmaceuticals. Cannabis oil: TO Pharmaceuticals. INM-755: InMed Pharmaceuticals. TO Pharmaceuticals.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52